CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension



Status:Recruiting
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:2/1/2019
Start Date:July 26, 2016
End Date:July 2019
Contact:Karen Mena
Email:clinicaltrialinfo@cidara.com
Phone:(858) 888-7868

Use our guide to learn which trials are right for you!

A Phase 2, Multicenter, Randomized, Double-blind Study of the Safety, Tolerability, and Efficacy of Intravenous CD101 vs Intravenous Caspofungin Followed by Oral Fluconazole Step-down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

The purpose of this study is to determine if intravenous CD101 is safe and effective in the
treatment of candidemia and/or invasive candidiasis when compared to caspofungin (followed by
oral fluconazole).

This Bridging Extension is to determine if intravenous CD101 is safe [Day 45- 52 for subjects
with candidemia only, or Day 52- 59 for subjects with invasive candidiasis with or without
candidemia] and effective [Day 14 (± 1 day)] in the treatment of candidemia and/or invasive
candidiasis when compared to caspofungin (followed by oral fluconazole).

Inclusion Criteria:

- mycological diagnosis of candidemia and/or invasive candidiasis from a sample taken
less than or equal to 96 hours before randomization (defined as: at least 1 blood
culture positive for Candida or positive test for Candida from a sponsor approved
rapid diagnostic test or positive gram stain for yeast or positive culture for Candida
spp. from a specimen obtained from a normally sterile site)

- willing to initiate or continue medical treatment to cure infections, including
receipt of antibiotics and surgical procedures, if required. Patients receiving only
medications and measures for comfort and not cure should not be enrolled.

- female subjects of child bearing potential <2 years post menopausal must agree to one
barrier method and one highly effective method of birth control or sexual abstinence.

- male subjects must be vasectomized, abstain from sexual intercourse, or agree to use
barrier contraception (condom with spermicide), and also agree not to donate sperm
from first dose of CD101 (Day 1) until 90 days following last administration of study
drug.

- willing and able to provide written informed consent. If the subject is unable to
consent for himself/herself, a legally acceptable representative must provide informed
consent on their behalf.

- presence of one or more systemic signs attributable to candidemia and/or invasive
candidiasis

Exclusion Criteria:

- Any of the following forms of IC:

1. Septic arthritis in a prosthetic joint (septic arthritis in a native joint is
allowed)

2. Osteomyelitis

3. Endocarditis or myocarditis

4. Meningitis, endophthalmitis, or any central nervous system infection

- neutropenia

- alanine aminotransferase or aspartate aminotransferase levels >10 fold the upper limit
of normal

- severe hepatic impairment in subjects with a history of chronic cirrhosis

- greater than 48 hours systemic antifungal treatment at approved doses to treat
candidemia

- pregnant females

- lactating females who are nursing

- known hypersensitivity to CD101, caspofungin, any echinocandin, or to any of their
excipients

- previous participation in this or any previous CD101 study

- recent use of an investigational medicinal product within 28 days of first dose of
study drug or presence of an investigational device at the time of screening

- Principal Investigator considers the subject should not participate

- presence of indwelling vascular catheter or device that cannot be removed and is
likely to be the source of candidemia
We found this trial at
17
sites
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
?
mi
from
Houston, TX
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
(601) 984-1000
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
1601 Northwest 12th Avenue
Miami, Florida 33136
(305) 243-6545
University of Miami Miller School of Medicine The University of Miami Leonard M. Miller School...
?
mi
from
Miami, FL
Click here to add this to my saved trials
Albany, New York 12208
?
mi
from
Albany, NY
Click here to add this to my saved trials
Augusta, Georgia 30912
?
mi
from
Augusta, GA
Click here to add this to my saved trials
121 Boulevard de Waterloo
Brussels, 1000
?
mi
from
Brussels,
Click here to add this to my saved trials
Butte, Montana 59701
?
mi
from
Butte, MT
Click here to add this to my saved trials
Davis, California 95616
?
mi
from
Davis, CA
Click here to add this to my saved trials
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Detroit, Michigan 48201
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Roanoke, VA
Click here to add this to my saved trials
Royal Oak, Michigan 48073
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
?
mi
from
Toledo, OH
Click here to add this to my saved trials
West Reading, Pennsylvania 19612
?
mi
from
West Reading, PA
Click here to add this to my saved trials